TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

More Selloff Strategies: Cramer's 'Mad Money' Recap (Friday 10/26/18)
JIM CRAMER

Fear of Big Sellers: Cramer's 'Mad Money' Recap

FedEx Shares Dive After Senior-Level Departure, Stock Downgrade
JIM CRAMER

FedEx, Funko, Amicus Therapeutics: 'Mad Money' Lightning Round

Top 5 Stock Winners in Dow Jones Industrial Average This Week
JIM CRAMER

The Game Plan: Cramer's 'Mad Money' Recap

Why Is Groupon on Sale? Look No Further Than Facebook, Google and Amazon
JIM CRAMER

Groupon, Wix.com, Las Vegas Sands: 'Mad Money' Lightning Round

FDA Publicly Shames Drug Companies to Encourage Generic Competition
REGULATION

Alkermes wins quick reversal from FDA on antidepressant drug

Premarket Biotech Movers: Portola, Esperion, Medicines
HEALTH

Portola Shares Lower After Pricing Stock Offering - Biotech Movers

Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Teligent Shares Rise on FDA Approval for Erythromycin Topical Gel

Mesoblast Soars on Stem-Cell Treatment Data
STOCKS

This $3 Biotech Stock Is Making an 11% Move Thursday

Arena Pharma's Stock Could Still Double Even After Tuesday's Epic Run
HEALTH

Biotech Movers: Arena Shares Skyrocket on Positive Data for Ralinepag

10 Highest-Paying Jobs in 2016 If All You Care About Is Money
HEALTH

Biotech Movers: Akari, Array, Amicus

Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Biotech Movers: Ionis, Alnylam, Amicus, Minerva

Spicer Declines to Comment on Trump's View of Export-Import Bank
STOCKS

Amicus CEO John Crowley, Not His Daughter Megan, Might Compel Trump to Make Big Changes at FDA

Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
STOCKS

Biotech premarket movers: Amicus Therapeutics, Nantkwest, Organovo

17 Thoughts on Biotech Stocks to Kick Off 2017
STOCKS

17 thoughts on biotech stocks to kick off 2017

Occidental Petroleum Expected to Earn 73 Cents a Share
STOCKS

5 stocks insiders love right now

Dow, S&P 500 and Nasdaq End at Record Highs on Trade Deal Progress
FUTURES

Futures flat as investors take profits; asia mixed

Hikma Shakes Up U.S. Operations After FDA Disappointment; CEO Said Darwazah to Lead Group
STOCKS

Amicus tumbles on lengthy delay to U.S. Fabry drug FDA filing plan

Valeant Acquires Eyegate Licensing Rights
MARKETS

Amicus (fold) ceo crowley to cnbc: 'our job is to stay focused and keep making great medicines'

Mobileye (MBLY) Stock Sinks After Morgan Stanley Cuts Price Target
MARKETS

Amicus therapeutics (fold) stock slumps on q2 loss

Amicus Shares Barely Budge on Prediction of $3 Billion Buyout
STOCKS

Amicus shares barely budge on prediction of $3 billion buyout

Ambarella (AMBA) Stock Falls in After-Hours Trading on Weak GoPro Sales Guidance
MARKETS

Amicus (FOLD) Stock Soars After EU Regulator Recommended Drug

Ziopharm Co-Dependency Spirals Down in Amended Intrexon Deal
STOCKS

Amicus Fabry drug closer to European approval.

Univar to Buy Nexeo for $2 Billion
OPINION

6 biotech stocks under $10 to trade for big breakouts

10 Highest-Paying Jobs in 2016 If All You Care About Is Money
OPINION

7 breakout stocks spiking on big volume

'Mad Money' Lightning Round: I'm Not Giving Up on VeriFone
JIM CRAMER

Cramer Buy, Buy, Buy Bristol-Myers Squibb